H.C. Wainwright Maintains Prothena(PRTA.US) With Buy Rating, Cuts Target Price to $48
Leerink Partners Maintains Prothena(PRTA.US) With Buy Rating, Cuts Target Price to $40
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Prothena Price Target Cut to $48.00/Share From $84.00 by HC Wainwright & Co.
Chardan Capital Initiates Coverage On Prothena Corp With Buy Rating, Announces Price Target of $40
Prothena Stock Gains 38% After Parkinson's Treatment Shows Potential Benefits
